Allergan (AGN) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail
Get Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Net earnings attributable to noncontrolling interest: 900K
Today's EPS Names:
PGR, OMID, ACI, More
Financial Fact:
Net earnings attributable to noncontrolling interest: 900K
Today's EPS Names:
PGR, OMID, ACI, More
Join SI Premium – FREE
Allergan (NYSE: AGN) reported Q2 EPS of $3.35, $0.01 better than the analyst estimate of $3.34. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $4.1 billion.
For earnings history and earnings-related data on Allergan (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UnitedHealth Group (UNH) Tops Q3 EPS by 57c, Beats on Revenue; Offers FY EPS Guidance
- ICICI Prudential Asset Management (ICICIAMC:IN) PT Lowered to INR3,330 at BofA Securities
- RBC Capital Downgrades Technology One Ltd (TNE:AU) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
